2029 Biosimilars Disease Drug Development 
Vial
MARCH 1, 2024
Growth factors for this market included the growing size of the pharmaceutical industry, the increasing number of clinical trials , substantial funds dedicated to pharma and biotech R&D, and the growing biosimilars and generics market. billion by 2029. By revenue, the largest CRO in the US was Thermo Fisher Scientific Inc.,
Drug Discovery World
JULY 26, 2024
Harris supports ‘march-in rights’ to allow public access to patented drugs at lower prices, a stance vehemently opposed by the industry which fears it will stifle innovation. Conversely, Trump champions free market competition and biosimilars. Projected revenues in India’s MedTech market this year are expected to top US$8.71billion.
Expert insights. Personalized for you.
52 
Let's personalize your content